Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I/II Clinical Study of Dose Escalation and Dose Expansion of SHR-1501 Alone or in Combination With Bacille de Calmette Guerin ???BCG??? or SHR-1316 in the Treatment of Non-muscle Invasive Bladder CancerNMIBC

Next Previous
Trial Profile

Phase I/II Clinical Study of Dose Escalation and Dose Expansion of SHR-1501 Alone or in Combination With Bacille de Calmette Guerin ???BCG??? or SHR-1316 in the Treatment of Non-muscle Invasive Bladder CancerNMIBC

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 31 Jan 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Adebrelimab (Primary) ; BCG (Primary) ; SHR 1501 (Primary) ; SHR 1501 (Primary)
  • Indications Bladder cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Shanghai Hengrui Pharmaceutical

Most Recent Events

  • 28 Jan 2025 Planned number of patients changed from 120 to 150.
  • 01 Aug 2024 Planned number of patients changed from 105 to 120.
  • 30 Jun 2023 Planned number of patients changed from 129 to 105.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top